Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Report Overview
2023
Base Year
2017-2023
Historical Year
2024-2032
Forecast Year
Global Phosphodiesterase (PDE) Inhibitors Market Outlook
The global phosphodiesterase (PDE) inhibitors market is projected to grow at a CAGR of 5.40% during the forecast period of 2024-2032. The increasing prevalence of erectile dysfunction (ED) and the growing demand for targeted therapy, such as PDE5 inhibitors, are driving the growth of the phosphodiesterase (PDE) inhibitors industry globally.
-inhibitors-market.png)
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Segmentation
A phosphodiesterase inhibitor belongs to a class of drugs inhibiting phosphodiesterase enzymes (PDEs), which normally break off phosphate groups, thus, preventing the growth of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) in target cells.
-inhibitors-market-by-administration.png)
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global phosphodiesterase (PDE) inhibitors industry can be broadly categorised based on its types, route of administration, applications, and regions.
- Type:
- PDE4 Inhibitors
- PDE5 Inhibitors
- Others
- Route of Administration:
- Oral
- Tropical
- Others
- Application:
- Erectile Dysfunction
- Chronic Obstructive Pulmonary Disease
- Others
The EMR report looks into the regional phosphodiesterase (PDE) inhibitors markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
-inhibitors-market-by-region.png)
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
Testosterone deficiency, prostate cancer, obesity, hypertension, hyperlipidemia, and intake of certain medicines, which could lead to erectile dysfunction, are the major factors for the industry growth. The high prevalence of these factors is leading to an increase in the incidences of erectile dysfunction (ED) conditions. The increased preference for PDE5 inhibitors, among other types, to treat ED and pulmonary hypertension is further aiding the industry growth. In addition, manufacturers are continuing to launch new PDE inhibitors with the advancement in technology, further expanding their therapeutic applications and increasing their sales. Region-wise, North America is expected to account for the largest share in the global industry over the forecast period owing to the increased penetration of the key players in the region.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global phosphodiesterase (PDE) inhibitors industry, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Bayer AG
- Eli Lilly and Co.
- GlaxoSmithKline Plc
- Pfizer Inc.
- Vivus Inc.
- Others
The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Route of Administration |
|
| Breakup by Application |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Key Questions Answered in the Report
The global phosphodiesterase (PDE) inhibitors market is projected to grow at a CAGR of 5.40% between 2023 and 2032.
The major drivers of the industry, such as the increasing population, increasing health awareness, growing incidences of erectile dysfunction (ED), increasing preference for targeted therapy, growing demand for PDE5 inhibitors, and rapid technological advancements, are expected to aid the market growth.
The launch of new and improved PDE inhibitor variants is the key market trend guiding the growth of the industry.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
PDE4 and PDE5 inhibitors are the leading types of phosphodiesterase (PDE) inhibitors in the industry.
Oral and tropical, among others, are the significant routes of administration available for phosphodiesterase (PDE) inhibitors in the market.
The leading applications of the product include erectile dysfunction and chronic obstructive pulmonary disease, among others.
The major players in the industry are Bayer AG, Eli Lilly and Co., Pfizer Inc., Vivus Inc., and GlaxoSmithKline plc, among others.
Purchase Full Report
Datasheet
- Selected Sections, One User
- Printing Not Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Single User License
One User
- All Sections, One User
- One Print Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
Five Users
- All Sections, Five Users
- Five Prints Allowed
- Email Delivery in PDF
- Free Limited Customisation
- Post Sales Analyst Support
50% Discount on Next Update
Corporate License
Unlimited Users
- All Sections, Unlimited Users
- Unlimited Prints Allowed
- Email Delivery in PDF + Excel
- Free Limited Customisation
- Post Sales Analyst Support
- 50% Discount on Next Update
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Subscribe to our Newsletter
By subscribing you agree to with our privacy policy and provide
consent to
receive
updates
from our company.
Our Offices
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124